Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 04 2021
Historique:
received: 10 07 2020
accepted: 22 03 2021
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 16 11 2021
Statut: epublish

Résumé

Samples in biobanks are generally preserved by formalin-fixation and paraffin-embedding (FFPE) and/or optimal cutting temperature compound (OCT)-embedding and subsequently frozen. Mass spectrometry (MS)-based analysis of these samples is now available via developed protocols, however, the differences in results with respect to preservation methods needs further investigation. Here we use bladder urothelial carcinoma tissue of two different tumor stages (Ta/T1-non-muscle invasive bladder cancer (NMIBC), and T2/T3-muscle invasive bladder cancer (MIBC)) which, upon sampling, were divided and preserved by FFPE and OCT. Samples were parallel processed from the two methods and proteins were analyzed with label-free quantitative MS. Over 700 and 1200 proteins were quantified in FFPE and OCT samples, respectively. Multivariate analysis indicates that the preservation method is the main source of variation, but also tumors of different stages could be differentiated. Proteins involved in mitochondrial function were overrepresented in OCT data but missing in the FFPE data, indicating that these proteins are not well preserved by FFPE. Concordant results for proteins such as HMGCS2 (uniquely quantified in Ta/T1 tumors), and LGALS1, ANXA5 and plastin (upregulated in T2/T3 tumors) were observed in both FFPE and OCT data, which supports the use of MS technology for biobank samples and encourages the further evaluation of these proteins as biomarkers.

Identifiants

pubmed: 33828141
doi: 10.1038/s41598-021-87003-6
pii: 10.1038/s41598-021-87003-6
pmc: PMC8027873
doi:

Substances chimiques

Biomarkers, Tumor 0
Fixatives 0
Proteins 0
Formaldehyde 1HG84L3525

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7595

Références

Anal Chem. 2018 May 1;90(9):5841-5849
pubmed: 29624047
Nat Immunol. 2017 May;18(5):583-593
pubmed: 28263321
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Am J Pathol. 2019 Mar;189(3):619-631
pubmed: 30770125
Annu Rev Biomed Eng. 2009;11:49-79
pubmed: 19400705
Nucleic Acids Res. 2020 Jan 8;48(D1):D1145-D1152
pubmed: 31686107
Anal Biochem. 2014 Feb 1;446:76-81
pubmed: 24161613
Int J Cancer. 2020 Jan 1;146(1):281-294
pubmed: 31286493
Epigenetics. 2008 Mar-Apr;3(2):64-8
pubmed: 18437052
Methods Enzymol. 2017;585:15-27
pubmed: 28109427
Cancer Biol Ther. 2006 Aug;5(8):967-75
pubmed: 16775426
Methods. 2015 Jun 15;81:50-5
pubmed: 25721092
BJU Int. 2009 Dec;104(11):1780-5
pubmed: 19522865
Nat Genet. 2003 Jan;33(1):90-6
pubmed: 12469123
Mol Cancer Res. 2011 Dec;9(12):1573-86
pubmed: 21970856
Oncotarget. 2014 Jan 30;5(2):506-18
pubmed: 24504108
Can J Gastroenterol Hepatol. 2019 Jul 1;2019:8348967
pubmed: 31355161
J Pathol. 2017 May;242(1):113-125
pubmed: 28195647
Clin Proteomics. 2018 Aug 3;15:26
pubmed: 30087585
J Proteomics. 2017 Aug 23;166:59-67
pubmed: 28709933
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
Mol Carcinog. 2008 Sep;47(9):678-85
pubmed: 18288642
Clin Cancer Res. 2012 Jun 15;18(12):3377-86
pubmed: 22553347
Sci Signal. 2018 Jan 30;11(515):
pubmed: 29382783
EuPA Open Proteom. 2015 Nov 02;10:9-18
pubmed: 29900094
Cell Mol Life Sci. 2016 May;73(10):2105-21
pubmed: 26781467
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
Pathology. 2012 Oct;44(6):506-12
pubmed: 22772342
Clin Chim Acta. 2014 Jan 1;427:42-8
pubmed: 24121031
Expert Opin Biol Ther. 2008 Jan;8(1):45-57
pubmed: 18081536
Oncol Rep. 2017 Sep;38(3):1605-1612
pubmed: 28731192
Pathol Res Pract. 2019 Aug;215(8):152464
pubmed: 31176575
J Proteome Res. 2011 Jul 1;10(7):3040-9
pubmed: 21526778
Genet Mol Res. 2013 May 06;12(2):1479-89
pubmed: 23765955
Methods Mol Biol. 2018;1711:133-148
pubmed: 29344888
Annu Rev Biochem. 2012;81:379-405
pubmed: 22439968
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Neoplasia. 2018 Sep;20(9):894-904
pubmed: 30121007
Proteomics. 2014 Mar;14(4-5):441-51
pubmed: 24339433
J Proteome Res. 2010 Jul 2;9(7):3688-700
pubmed: 20469934

Auteurs

Alberto Valdés (A)

Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Box 599, 751 24, Uppsala, Sweden.
Laboratory of Foodomics, Institute of Food Science Research, CIAL, CSIC, Nicolás Cabrera 9, 28049, Madrid, Spain.

Athanasios Bitzios (A)

Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Box 599, 751 24, Uppsala, Sweden.

Eszter Kassa (E)

Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Box 599, 751 24, Uppsala, Sweden.

Ganna Shevchenko (G)

Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Box 599, 751 24, Uppsala, Sweden.

Alexander Falk (A)

Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Box 599, 751 24, Uppsala, Sweden.

Per-Uno Malmström (PU)

Department of Surgical Science, Urology, Akademiska Hospital, Uppsala University, 751 85, Uppsala, Sweden.

Anca Dragomir (A)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Department of Pathology, Uppsala University Hospital, 751 85, Uppsala, Sweden.

Ulrika Segersten (U)

Department of Surgical Science, Urology, Akademiska Hospital, Uppsala University, 751 85, Uppsala, Sweden.

Sara Bergström Lind (SB)

Department of Chemistry-BMC, Analytical Chemistry, Uppsala University, Box 599, 751 24, Uppsala, Sweden. sara.lind@uadm.uu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH